Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.
Burlile JF, Frechette KM, Breen WG, Hwang SR, Higgins AS, Nedved AN, Harmsen WS, Pulsipher SD, Witzig TE, Micallef IN, Hoppe BS, Habermann TM, Thanarajasingam G, Johnston PB, Inwards DJ, Bennani NN, Peterson JL, Stish BJ, Rule WG, Ansell SM, Lester SC.
Burlile JF, et al.
Blood Adv. 2024 Mar 12;8(5):1250-1257. doi: 10.1182/bloodadvances.2023011533.
Blood Adv. 2024.
PMID: 38206755
Free PMC article.